Skip to main content
Log in

C. difficile vaccine cost effective for prevention of nosocomial CDI

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2019 Canadian dollars

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

C. difficile vaccine cost effective for prevention of nosocomial CDI. PharmacoEcon Outcomes News 847, 4 (2020). https://doi.org/10.1007/s40274-020-6580-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6580-4

Navigation